The Health path (02587) prices at HK$7.8 per share, Hong Kong public offering received 34.42 times oversubscribed.

HealthPath (02587) announced the results of its share allocation, with 25 million H shares sold globally. The public offering in Hong Kong accounted for 13.2% of the total, while the international allocation accounted for 86.8%. The final offering price was set at HK$7.8 per share, raising a net amount of approximately HK$109 million. Trading of the H shares is expected to commence on December 30, 2024, at 9:00 am on the Hong Kong Stock Exchange. The public offering in Hong Kong was oversubscribed by 34.42 times, while the international allocation was oversubscribed by 0.98 times.